EUVIMEDEUVIMED entdecken
Crossref

Are nucleot(s)ide analogues a negative factor for HBsAg seroconversion in acute hepatitis B?

M F Keser, M A Erdogan, O Yıldırım

Acta Gastro Enterologica Belgica · 2024

DOI: 10.51821/87.3.12462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Gastro Enterologica Belgica, 2024. Verfasst von M F Keser und 2 weiteren Autor:innen. Beteiligte Einrichtung: Battalgazi State Hospital, Internal Medicine Clinic, Malatya, Turkey. Hauptthemen laut MEDLINE: Seroconversion, Hepatitis B Surface Antigens, Antiviral Agents, Tenofovir. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and study aim: There are several studies comparing patients treated with lamivudine and those not given antiviral therapy in acute hepatitis B. Some of these studies showed that antiviral treatment significantly contributed to survival, whereas one other study suggested that antiviral treatment had no effect. The aim of this study was to investigate the efficacy of tenofovir disoproxil fumarate (TDF) therapy and its effect on HBsAg seroconversion in patients with acute viral hepatitis B. Patients and methods: The files of 126 patients who were under follow-up for acute HBV infection in the Department of Gastroenterology were analyzed retrospectively. Demographic data, molecular, ELISA, and biochemistry tests at the time of diagnosis and in the follow-up, period were evaluated using the hospital automation system. Results: The rate of chronicity of HBV was found to be higher in the TDF group than in the group without antiviral treatment. The rate of protective anti-HBs acquisition was found to be lower in the TDF group (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SeroconversionHepatitis B Surface AntigensAntiviral AgentsTenofovirHepatitis BHumansFemaleMaleRetrospective StudiesAdultMiddle AgedAcute Disease

Stichwörter der Autor:innen

acute hepatitis Breactivationseroconversion

Substanzen

Hepatitis B Surface AntigensAntiviral AgentsTenofovir

Autor:innen und Institutionen

  • Battalgazi State Hospital, Internal Medicine Clinic, Malatya, Turkey.
  • Inonu University, School of Medicine, Department of Gastroenterology, Malatya, Turkey.

Zitieren

APA

Keser, M. F., Erdogan, M. A., & Yıldırım, O. (2024). Are nucleot(s)ide analogues a negative factor for HBsAg seroconversion in acute hepatitis B?. Acta Gastro Enterologica Belgica. https://doi.org/10.51821/87.3.12462

Vancouver

Keser MF, Erdogan MA, Yıldırım O. Are nucleot(s)ide analogues a negative factor for HBsAg seroconversion in acute hepatitis B?. Acta Gastro Enterologica Belgica. 2024. doi:10.51821/87.3.12462

BibTeX
@article{Keser2024,
  author = {Keser, M F and Erdogan, M A and Yıldırım, O},
  title = {Are nucleot(s)ide analogues a negative factor for HBsAg seroconversion in acute hepatitis B?},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2024},
  doi = {10.51821/87.3.12462}
}
Kostenlos starten →